An expert highlighted unmet needs in treating T-cell acute lymphoblastic leukemia and where research may focus in the future.

The "Cutaneous T-cell lymphoma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive insights about 25+ companies and 30+ ...

上述结果表明，自体抗CD7 PEBL-CAR T细胞具有强大的抗白血病活性，是治疗T-ALL的潜在有效选择。这也意味着抗CD7 PEBL-CAR T细胞能够克服限制当前复发或难治性T-ALL治疗的耐药机制，为患者带来希望。

近期，该研究团队在 Nature Medicine上发表了题为 Fratricide-resistant CD7-CAR T cells in T-ALL的论文， 报告了17例接受自体抗CD7 PEBL-CAR T细胞治疗的T-ALL患者的 ...

A 13-year-old girl’s battle with cancer has been transformed by a revolutionary medical breakthrough, offering new hope to ...

The FDA has lifted clinical holds on trials of zevor-cel, satri-cel, and CT071, and trials will now resume in the US. A single infusion of the autologous GPRC5D-targeted CAR T-cell therapy BMS-986393 ...

T cells are white blood cells that are important for adaptive immunity. They have unique cell surface receptors that are generated by randomly assorting genes. These receptors allow T cells to ...